Published 13 hours ago • loading... • Updated 2 hours ago

Eli Lilly Becomes First Trillion-Dollar Health Company

On Nov. 21, Eli Lilly reached a $1 trillion market valuation in trading Friday, briefly crossing the threshold before its stock pulled back in U.S. stock markets.
Lilly's surge follows sales of Mounjaro and Zepbound, which generated $11.54 billion and $4.93 billion by 2024, while shares rose more than 36% this year.
After winning approvals, Lilly now faces intensified competition as Pfizer paid $10 billion for Metsera earlier this month and two new injectable obesity drugs enter trials.
Some analysts predict the market could exceed $150 billion by the early 2030s, and Eli Lilly expects continued growth as insurance and approvals expand access with an oral version next year.
As a rare non-tech trillion-dollar firm, Eli Lilly is the first healthcare company to reach $1 trillion and only the second after Warren Buffett's Berkshire Hathaway, founded in 1876 with milestones like 1923's insulin and Prozac.

Insights by Ground AI

24 Articles

This Healthcare Company Just Touched $1 Trillion in Market Cap. Should You Invest $1,000?

Key PointsEli Lilly has a dominant share of the huge and expanding GLP-1 drug market.Its GLP-1 drugs will soon be partially covered by Medicare.Lilly is close to releasing a pill form of its best-selling drug.10 stocks we like better than Eli Lilly › Just a handful of companies have entered the rarefied trillionaire club. So far, it's been limited to huge technology companies like the Magnificent Seven, plus oil giant Saudi Aramco and Warren Buf…

2 hours ago·Alexandria, United States

Read Full Article